Teacher Retirement System of Texas boosted its stake in shares of Stryker Co. (NYSE:SYK – Free Report) by 31.9% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 155,333 shares of the medical technology company’s stock after acquiring an additional 37,557 shares during the period. Teacher Retirement System of Texas’ holdings in Stryker were worth $55,928,000 at the end of the most recent quarter.
Other large investors also recently added to or reduced their stakes in the company. Kohmann Bosshard Financial Services LLC acquired a new position in Stryker during the fourth quarter worth $25,000. Dunhill Financial LLC raised its position in Stryker by 94.9% during the third quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company’s stock worth $27,000 after acquiring an additional 37 shares during the period. Rakuten Securities Inc. grew its holdings in shares of Stryker by 618.2% during the fourth quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company’s stock worth $28,000 after buying an additional 68 shares in the last quarter. Centricity Wealth Management LLC purchased a new stake in shares of Stryker during the fourth quarter worth $30,000. Finally, BankPlus Trust Department purchased a new stake in shares of Stryker during the fourth quarter worth $33,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
SYK has been the subject of a number of research reports. Argus set a $450.00 target price on shares of Stryker in a report on Monday, February 3rd. Citigroup reaffirmed a “buy” rating and set a $450.00 target price on shares of Stryker in a report on Wednesday, February 26th. Wells Fargo & Company upped their target price on shares of Stryker from $427.00 to $435.00 and gave the stock an “overweight” rating in a report on Wednesday, January 29th. JMP Securities reaffirmed a “market perform” rating on shares of Stryker in a report on Tuesday, February 18th. Finally, The Goldman Sachs Group set a $422.00 price objective on shares of Stryker in a report on Tuesday, March 4th. Five research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $421.90.
Insider Transactions at Stryker
In related news, Director Ronda E. Stryker sold 201,392 shares of the firm’s stock in a transaction that occurred on Friday, January 31st. The shares were sold at an average price of $392.24, for a total value of $78,993,998.08. Following the sale, the director now owns 3,642,075 shares of the company’s stock, valued at $1,428,567,498. This trade represents a 5.24 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Allan C. Golston sold 2,458 shares of the firm’s stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total transaction of $941,586.06. Following the completion of the sale, the director now directly owns 14,895 shares in the company, valued at approximately $5,705,827.65. This trade represents a 14.16 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 5.90% of the company’s stock.
Stryker Trading Down 1.2 %
Shares of SYK stock opened at $373.69 on Friday. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. The firm has a market cap of $142.59 billion, a PE ratio of 48.16, a price-to-earnings-growth ratio of 2.93 and a beta of 0.95. The company has a 50-day moving average of $384.18 and a two-hundred day moving average of $373.85. Stryker Co. has a 1-year low of $314.93 and a 1-year high of $406.19.
Stryker (NYSE:SYK – Get Free Report) last issued its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same quarter in the previous year, the firm earned $3.46 EPS. On average, analysts predict that Stryker Co. will post 13.47 EPS for the current year.
Stryker Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be given a dividend of $0.84 per share. The ex-dividend date is Monday, March 31st. This represents a $3.36 annualized dividend and a dividend yield of 0.90%. Stryker’s dividend payout ratio is presently 43.30%.
Stryker Profile
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.
See Also
- Five stocks we like better than Stryker
- How to start investing in penny stocks
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- How to Invest in Biotech Stocks
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- How to Choose Top Rated Stocks
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.